Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
Andrew L CovelerDavid C SmithTycel PhillipsBrendan D CurtiSanjay GoelAmitkumar N MehtaTimothy M KuzelSvetomir N MarkovicOlivier RixeDavid L BajorThomas F GajewskiMartin GutierrezHun Ju LeeAjay K GopalPaolo CaimiElisabeth I HeathJohn A ThompsonSahar AnsariCeline JacquemontAriel Topletz-EricksonPeigen ZhouMichael W SchmittJuneko E Grilley-OlsonPublished in: Journal for immunotherapy of cancer (2023)
NCT02376699.